Last update 08 May 2025

BAZ2B x BAZ2A x CECR2

Basic Info

Related Targets
BAZ2BBAZ2ACECR2

Related

1
Drugs associated with BAZ2B x BAZ2A x CECR2
GSK2801
Target
BAZ2A x BAZ2B x CECR2
Mechanism
BAZ2A inhibitors [+2]
Active Org.
GSK PlcGSK Plc
Originator Org.
GlaxoSmithKline, Inc.
Active Indication-
Inactive Indication-
Drug Highest PhasePreclinical
First Approval Ctry. / Loc.-
First Approval Date20 Jan 1800
100 Clinical Results associated with BAZ2B x BAZ2A x CECR2
Login to view more data
100 Translational Medicine associated with BAZ2B x BAZ2A x CECR2
Login to view more data
0 Patents (Medical) associated with BAZ2B x BAZ2A x CECR2
Login to view more data

Analysis

Perform a panoramic analysis of this field.
login
or
view full example data
Perform a panoramic analysis of this field.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free